With origins in Paris, Besins Healthcare has been a pioneer in hormone replacement therapy for five generations.
Besins Healthcare is a privately held, global pharmaceutical company headquarted in Monaco.
We are a world leader in novel therapies for gynaecology and andrology. We have discovered ground-breaking technologies to improve patient well-being throughout our history. We developed several hormone therapies over the years including bioavailable natural progesterone by different routes of administration for pregnant women from conception until delivery and a natural testosterone transdermal gel for testosterone deficiency syndrome. We continue to be a leader in Estradiol Replacement Therapy with the first transdermal gel marketed in Europe.
Our products are trusted and prescribed by healthcare professionals in more than 100 countries throughout the world.
In June 2014 Besins established a local affiliate, Besins Healthcare Australia, so that we can better support Australian doctors and patients.
For over 40 years, Besins Healthcare has discovered, developed and delivered healthcare solutions for women.
We’ve developed Testogel® used in adult men to replace the body’s natural hormone testosterone.
Our goal is to create long-term mutually beneficial relationships with our commercial partners.
A focus on research and innovation
Today, our discovery and development efforts are focused on gynaecology, fertility, obstetric conditions and androgen deficiency — a core set of therapeutic areas where we have proven expertise. Besins is actively supporting more than 40 investigator-initiated trials worldwide.
We look forward to a future where we introduce additional innovative healthcare solutions in Australia.